PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Kapo Saukkonen
Jaana Hagström
Harri Mustonen
Anne Juuti
Stig Nordling
Pauliina Kallio
Kari Alitalo
Hanna Seppänen
Caj Haglund
机构：
[1] University of Helsinki and Helsinki University Hospital,Department of Surgery
[2] University of Helsinki,Research Programs Unit, Translational Cancer Biology
[3] University of Helsinki and Helsinki University Hospital,Department of Pathology, Haartman Institute and HUSLAB
来源：
BMC Cancer | / 16卷
关键词：
Pancreatic ductal adenocarcinoma; Beta-catenin; PROX1; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
    Wang, Lai Mun
    Silva, Michael A.
    D'Costa, Zenobia
    Bockelmann, Robin
    Soonawalla, Zahir
    Liu, Stanley
    O'Neill, Eric
    Mukherjee, Somnath
    McKenna, W. Gillies
    Muschel, Ruth
    Fokas, Emmanouil
    ONCOTARGET, 2016, 7 (04) : 4183 - 4194
  • [32] A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
    Lingyu Zhu
    Shuo Shen
    Huan Wang
    Guoxiao Zhang
    Xiaoyi Yin
    Xiaohan Shi
    Suizhi Gao
    Jiawei Han
    Yiwei Ren
    Jian Wang
    Hui Jiang
    Shiwei Guo
    Gang Jin
    BMC Cancer, 23
  • [33] Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
    Xu, Yongfeng
    Xiong, Qunli
    Yang, Yang
    Weng, Ningna
    Li, Junjun
    Liu, Jinlu
    Yang, Xiaojuan
    Zeng, Zhu
    Zhang, Zhiwei
    Zhu, Qing
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [34] Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma
    Osei-Bordom, Daniel C.
    Sachdeva, Gagandeep
    Christou, Niki
    FRONTIERS IN MEDICINE, 2022, 8
  • [35] Prognostic significance of circulating tumor microemboli in patients with pancreatic ductal adenocarcinoma
    Wu, Guangdong
    Zhu, Rongrong
    Li, Yatong
    Zhao, Yupei
    Dai, Menghua
    ONCOLOGY LETTERS, 2018, 15 (05) : 7376 - 7382
  • [36] Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma
    Pyo, Jung-Soo
    Son, Byoung Kwan
    Lee, Hyo Young
    Oh, Il Hwan
    Chung, Kwang Hyun
    CURRENT ONCOLOGY, 2021, 28 (06) : 4367 - 4376
  • [37] Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma
    Kanai, Tomoya
    Ito, Zensho
    Oji, Yusuke
    Suka, Machi
    Nishida, Sumiyuki
    Takakura, Kazuki
    Kajihara, Mikio
    Saruta, Masayuki
    Fujioka, Shuichi
    Misawa, Takeyuki
    Akiba, Tadashi
    Yanagisawa, Hiroyuki
    Shimodaira, Shigetaka
    Okamoto, Masato
    Sugiyama, Haruo
    Koido, Shigeo
    ONCOLOGY LETTERS, 2018, 16 (02) : 2682 - 2692
  • [38] Genomics of pancreatic ductal adenocarcinoma
    Pilarsky, Christian
    Gruetzmann, Robert
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2014, 13 (04) : 381 - 385
  • [39] Plasma COL10A1 Level, a Potential Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma
    Wang, Tianlei
    Bao, Xinrui
    Yang, Fang
    Pan, Shenbin
    Xu, Ke
    Ren, Tao
    ONCOTARGETS AND THERAPY, 2024, 17 : 949 - 959
  • [40] Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma
    Wang, Minhua
    Estrella, Jeannelyn S.
    Katz, Matthew H.
    Kim, Michael
    Rashid, Asif
    Lee, Jeffrey E.
    Maitra, Anirban
    Wistuba, Ignacio I.
    Wolff, Robert A.
    Varadhachary, Gauri R.
    Wang, Huamin
    PANCREAS, 2019, 48 (10) : 1367 - 1372
12345